PACS — PACS Group, Inc.

PACS Group Q2 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: $1.43 billion, up 9.1% year-over-year.
• Net Income: $76.4 million, a 50% increase from the prior year.
• Adjusted EBITDA: $166.8 million, up 25% year-over-year, with an adjusted EBITDA margin expanding from 10.2% to 11.7%.
• Adjusted EPS: Increased 34% to $0.63.
• Same-store Revenue Growth: 5.8% increase in skilled nursing revenue.
• Occupancy Rates: Increased to 90.4% from 88.6% year-over-year; same-store occupancy improved by 150 basis points to 90.6%.
• Skilled Mix: Increased to 30% from 29% year-over-year.

2. Strategic Updates and Business Highlights

• PACS operates 324 healthcare facilities across 17 states, with a focus on improving quality outcomes and operational efficiency.
• Successful turnaround of a previously distressed facility in California, which graduated from the Special Focus Facility program, showcasing PACS's operational model.
• Acquisition of 34 skilled nursing facilities from Eduro Healthcare, with the first 20 facilities closed on August 1, 2026. This acquisition is expected to enhance PACS's presence in Texas and leverage existing operational strengths.
• Continued focus on quality care, with 83.6% of skilled nursing facilities rated 4 or 5 stars by CMS, significantly above the industry average.

3. Forward Guidance and Outlook

• Revenue Guidance: Increased to $5.75 billion - $5.85 billion for 2026, reflecting a 10% growth over the previous year.
• Adjusted EBITDA Guidance: Raised to $640 million - $660 million, indicating a 29% increase over 2025.
• Guidance includes modest contributions from the recently acquired Texas facilities but excludes contributions from remaining Eduro facilities pending closure.

4. Bad News, Challenges, or Points of Concern

• Ongoing government investigations were mentioned, with PACS cooperating fully but unable to estimate resolution timing.
• Material weaknesses in internal controls over financial reporting are being addressed, with remediation expected by year-end.
• Increased general and administrative expenses, attributed to investments in compliance and personnel, which may affect short-term profitability.

5. Notable Q&A Insights

• Management emphasized the importance of quality metrics in securing payer contracts, highlighting that high-quality care leads to better negotiation positions.
• Discussions around labor dynamics revealed improvements in labor availability and reduced reliance on temporary staff, contributing to margin expansion.
• The pipeline for acquisitions is robust, with a mix of smaller and larger deals, providing strategic flexibility.
• Medicaid reimbursement rates are expected to continue increasing, supported by PACS's focus on quality care and engagement with state-level decision-makers.

Overall, PACS Group reported strong financial performance in Q2 2026, driven by organic growth and strategic acquisitions, while also addressing challenges related to compliance and operational integration. The outlook remains positive, with increased guidance reflecting confidence in ongoing operational improvements and market opportunities.